Rchr
J-GLOBAL ID:201801020747562430   Update date: Feb. 01, 2024

Ueda Yasutaka

ウエダ ヤスタカ | Ueda Yasutaka
Affiliation and department:
Job title: Assistant Professor
Research field  (1): Hematology and oncology
Research keywords  (4): Complement Diseases ,  Paroxysmal Nocturnal Hemoglobinuria ,  Bone Marrow Failure Syndromes ,  Hematology
Research theme for competitive and other funds  (6):
  • 2022 - 2025 PNHクローンの起源と変遷
  • 2019 - 2022 Identification of the most appropriate therapeutic target for PNH
  • 2019 - 2020 Analysis for hematopoietic dynamics of clonal expansion in PNH
  • 2017 - 2020 Elucidation of mechanism of pathogenesis of paroxysmal nocturnal hemoglobinuria
  • 2015 - 2018 Exhaustive analysis for clinical application of anti-complement drugs
Show all
Papers (39):
  • Ken Ishiyama, Yuji Yonemura, Tatsuya Kawaguchi, Kohei Hosokawa, Chiharu Sugimori, Yasutaka Ueda, Hiroyuki Takamori, Naoshi Obara, Hideyoshi Noji, Yukari Shirasugi, et al. A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan. British journal of haematology. 2023
  • Jun-Ichi Nishimura, Antoine Soubret, Noriko Arase, Simon Buatois, Masaki Hotta, Jean-Eric Charoin, Yoshikazu Ito, Sasha Sreckovic, Hiroyuki Takamori, Christoph Bucher, et al. Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 Inhibitors. Clinical pharmacology and therapeutics. 2023. 113. 4. 904-915
  • 植田 康敬, 高森 弘之, 加藤 保宏, 森田 貴義, 堤 一仁, 一井 倫子, 西村 純一, 熊ノ郷 淳, 保仙 直毅. 発作性夜間ヘモグロビン尿症に対する新型コロナウィルスワクチンの有効性と安全性の検討. 補体. 2022. 59. 1. 57-58
  • 植田康敬, 高森弘之, 加藤保宏, 森田貴義, 堤一仁, 一井倫子, 西村純一, 熊ノ郷淳, 保仙直毅. 発作性夜間ヘモグロビン尿症に対する新型コロナウィルスワクチンの有効性と安全性の検討. 補体. 2022. 59. 1. 57-58
  • Takayuki Ikezoe, Hideyoshi Noji, Yasutaka Ueda, Yoshinobu Kanda, Shinichiro Okamoto, Kensuke Usuki, Takahisa Matsuda, Hirozumi Akiyama, Akihiko Shimono, Yuji Yonemura, et al. Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan. International journal of hematology. 2022. 115. 4. 470-480
more...
MISC (36):
  • 植田 康敬. 寒冷凝集素症と抗補体薬. 補体. 2022. 59. 1. 22-23
  • 植田康敬. Recent progress in the treatment of paroxysmal nocturnal hemoglobinuria. 月刊血液内科. 2022. 85. 1. 63-69
  • 植田 康敬. 【見逃さない!潜んでいる血液疾患-気づきのためのポイント集】発作性夜間ヘモグロビン尿症. カレントテラピー. 2022. 40. 6. 535-540
  • 植田 康敬. 【血液疾患のすべて】赤血球系疾患 溶血性貧血. 日本医師会雑誌. 2022. 151. 特別1. S184-S186
  • Yasutaka Ueda. [Thrombotic risk in autoimmune hemolytic anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2022. 63. 6. 608-617
more...
Books (2):
  • EBM血液疾患の治療2023-2024
    中外医学社 2022 ISBN:9784498225404
  • 血液専門医テキスト
    南江堂 2019 ISBN:9784524248827
Lectures and oral presentations  (11):
  • Trial in Progress: Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Cold Agglutinin Disease (CASCADE)
    (64th American Soceity of Hematology Annual Meeting and Expostion)
  • Importance of controling intravascular hemolysis in PNH -what we learned in the past 10 years-
    (2022)
  • Advances in understanding of pathogenesis and treatment of autoimmune hemolytic anemia.
    (2022)
  • Cold agglutini disease and comlement inhibitors
    (2022)
  • Safety and Efficacy of SARS-CoV-2 mRNA Vaccination in Paroxysmal Nocturnal Hemoglobinuria Patients:An Institutional Experience
    (2022)
more...
Education (2):
  • 2002 - 2008 Osaka University Graduate School of Medicine
  • 1993 - 1999 Osaka University Faculty of Medicine Medical School
Work history (1):
  • 2011/07 - 2014/06 National Heart, Lung, and Blood Institute, National Institutes of Health VIsiting Fellow
Committee career (2):
  • 2022/11 - 現在 The Japanese Society of Hematology Program planning committee member
  • 2021/09 - 現在 日本血液学会 試験問題作成委員
Awards (3):
  • 2021/03 - Intractable disease research grant
  • 2020/12 - 大阪大学大学院医学系研究科・医学部附属病院産学連携・クロスイノベーションイニシア ティブ 令和2 年度新型コロナウイルス対策研究開発助成事業 COVID-19血栓性微小血管障害における補体活性化の意義の解明
  • 2011/06 - 住友生命社会福祉事業団 海外医学研究助成
Association Membership(s) (5):
THE JAPANESE BIOCHEMICAL SOCIETY ,  The Japan Society for Hematopoietic Cell Transplantation ,  American Society of Hematology ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPANESE SOCIETY OF HEMATOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page